| Level/ Typ |
Code |
Anzeigename |
Codesystem |
| 0‑L |
100-8
|
Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
101-6
|
Cefoperazone [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
103-2
|
Ceforanide [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
104-0
|
Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
105-7
|
Ceforanide [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
10653-4
|
Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
10654-2
|
Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
10697-1
|
Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
10698-9
|
Nystatin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
10720-1
|
Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
10721-9
|
Terbinafine [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
107-3
|
Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
108-1
|
Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
10868-8
|
Bacitracin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
109-9
|
Cefotaxime [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
121-4
|
Cefpodoxime [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
111-5
|
Cefotetan [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
112-3
|
Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
113-1
|
Cefotetan [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
115-6
|
Cefoxitin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
11575-8
|
Cefmetazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
11576-6
|
Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
11577-4
|
Sulfamethoxazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
11578-2
|
Sulfisoxazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
116-4
|
Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
11-7
|
Amikacin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
117-2
|
Cefoxitin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
129-7
|
Cefsulodin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
119-8
|
Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
120-6
|
Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
123-0
|
Cefprozil [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
124-8
|
Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
12-5
|
Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
125-5
|
Cefprozil [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
138-8
|
Ceftizoxime [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
127-1
|
Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
128-9
|
Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
132-1
|
Ceftazidime [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
13-3
|
Amikacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
133-9
|
Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
134-7
|
Ceftazidime [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
136-2
|
Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
137-0
|
Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
13968-3
|
Penicillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
140-4
|
Ceftriaxone [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
141-2
|
Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
142-0
|
Ceftriaxone [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
14332-1
|
Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
144-6
|
Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
145-3
|
Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
152-9
|
Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
146-1
|
Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
148-7
|
Cephalexin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
149-5
|
Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
150-3
|
Cephalexin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
153-7
|
Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
154-5
|
Cephaloglycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
156-0
|
Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
157-8
|
Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
15-8
|
Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
158-6
|
Cephaloridine [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
160-2
|
Cephalothin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
16099-4
|
Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
161-0
|
Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
16100-0
|
Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
162-8
|
Cephalothin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
16387-3
|
Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
16421-0
|
Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
164-4
|
Cephapirin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
165-1
|
Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
16-6
|
Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
16620-7
|
Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
16623-1
|
Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
166-9
|
Cephapirin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
16830-2
|
Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
16841-9
|
Ethambutol+Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
168-5
|
Cephradine [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
173-5
|
Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
176-8
|
Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
169-3
|
Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
170-1
|
Cephradine [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
172-7
|
Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
17-4
|
Amoxicillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
174-3
|
Chloramphenicol [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
177-6
|
Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
178-4
|
Chlortetracycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
182-6
|
Cinoxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
1-8
|
Acyclovir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
180-0
|
Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
181-8
|
Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18946-4
|
Metronidazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18947-2
|
Mezlocillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18948-0
|
Minocycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18949-8
|
Miocamycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18950-6
|
Moxalactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18951-4
|
Nafcillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18952-2
|
Nalidixate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18953-0
|
Neomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18954-8
|
Netilmicin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18955-5
|
Nitrofurantoin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18956-3
|
Norfloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18957-1
|
Novobiocin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18958-9
|
Nystatin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
184-2
|
Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
198-2
|
Cloxacillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
185-9
|
Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
186-7
|
Ciprofloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
188-3
|
Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18855-7
|
5-Fluorocytosine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18857-3
|
Almecillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18859-9
|
Amdinocillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18860-7
|
Amikacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18861-5
|
Amoxicillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18862-3
|
Amoxicillin+Clavulanate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18863-1
|
Amphotericin B [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18864-9
|
Ampicillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18865-6
|
Ampicillin+Sulbactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18866-4
|
Azithromycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18867-2
|
Azlocillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18868-0
|
Aztreonam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18869-8
|
Bacampicillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18870-6
|
Bacitracin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18871-4
|
Butirosin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18872-2
|
Capreomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18873-0
|
Carbenicillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18874-8
|
Cefaclor [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18875-5
|
Cefadroxil [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18876-3
|
Cefamandole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18877-1
|
Cefatrizine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18878-9
|
Cefazolin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18879-7
|
Cefepime [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18880-5
|
Cefixime [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18881-3
|
Cefmetazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18882-1
|
Cefodizime [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18883-9
|
Cefonicid [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18884-7
|
Cefoperazone [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18885-4
|
Ceforanide [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18886-2
|
Cefotaxime [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18887-0
|
Cefotetan [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18888-8
|
Cefoxitin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18889-6
|
Cefpirome [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18890-4
|
Cefpodoxime [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18891-2
|
Cefprozil [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18892-0
|
Cefsulodin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18893-8
|
Ceftazidime [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18894-6
|
Ceftizoxime [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18895-3
|
Ceftriaxone [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18896-1
|
Cefuroxime Parenteral [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18897-9
|
Cephalexin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18898-7
|
Cephaloglycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18899-5
|
Cephaloridine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18900-1
|
Cephalothin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18901-9
|
Cephapirin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18902-7
|
Cephradine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18903-5
|
Chloramphenicol [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18904-3
|
Chlortetracycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18905-0
|
Cinoxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18906-8
|
Ciprofloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18907-6
|
Clarithromycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18908-4
|
Clindamycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18909-2
|
Clotrimazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
189-1
|
Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18910-0
|
Cloxacillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18911-8
|
Colistimethate
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18912-6
|
Colistin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18913-4
|
Cyclacillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18914-2
|
Cycloserine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18915-9
|
Demeclocycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18916-7
|
Dicloxacillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18917-5
|
Doxycycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18918-3
|
Enoxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18919-1
|
Erythromycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18920-9
|
Erythromycin+Sulfisoxazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18921-7
|
Ethambutol [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18922-5
|
Ethionamide [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18923-3
|
Floxacillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18924-1
|
Fluconazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18926-6
|
Framycetin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18927-4
|
Fusidate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18928-2
|
Gentamicin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18929-0
|
Gentamicin.high potency [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18930-8
|
Gramicidin D [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18931-6
|
Hetacillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18932-4
|
Imipenem [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18934-0
|
Isoniazid [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18935-7
|
Kanamycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18936-5
|
Kanamycin.high potency [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18937-3
|
Ketoconazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18938-1
|
Lincomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18939-9
|
Lomefloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18940-7
|
Loracarbef [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18941-5
|
Lymecycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18942-3
|
Meclocycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18943-1
|
Meropenem [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18944-9
|
Methacycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18945-6
|
Methicillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18959-7
|
Ofloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18960-5
|
Oleandomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18961-3
|
Oxacillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18962-1
|
Oxytetracycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18963-9
|
Pefloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18964-7
|
Penicillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18965-4
|
Penicillin G [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18966-2
|
Penicillin V [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18967-0
|
Phenethicillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18968-8
|
Pipemidate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18969-6
|
Piperacillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18970-4
|
Piperacillin+Tazobactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18971-2
|
Pivampicillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18972-0
|
Polymyxin B [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18973-8
|
Pyrazinamide [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18974-6
|
Rifampin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18975-3
|
Ristocetin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18976-1
|
Rolitetracycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18977-9
|
Rosoxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18978-7
|
Roxithromycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18979-5
|
Sisomicin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18980-3
|
Spectinomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18981-1
|
Spiramycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18982-9
|
Streptomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18983-7
|
Streptomycin.high potency [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18984-5
|
Sulfadiazine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18985-2
|
Sulfamethoxazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18986-0
|
Sulfisoxazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18987-8
|
Sulfonamide [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18988-6
|
Talampicillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18989-4
|
Teicoplanin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18990-2
|
Temafloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18991-0
|
Temocillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18992-8
|
Terbinafine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18993-6
|
Tetracycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18994-4
|
Ticarcillin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18995-1
|
Ticarcillin+Clavulanate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18996-9
|
Tobramycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18997-7
|
Trimethoprim [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18998-5
|
Trimethoprim+Sulfamethoxazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
18999-3
|
Troleandomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
19-0
|
Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
19000-9
|
Vancomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
19001-7
|
Viomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
190-9
|
Clarithromycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
19149-4
|
Rifabutin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
192-5
|
Clindamycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
193-3
|
Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
194-1
|
Clindamycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20375-2
|
Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20376-0
|
Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20377-8
|
Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20378-6
|
Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20379-4
|
Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
196-6
|
Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
197-4
|
Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
200-6
|
Colistimethate by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
201-4
|
Colistimethate by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
202-2
|
Colistimethate by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20373-7
|
Amikacin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20374-5
|
Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20380-2
|
Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20381-0
|
Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20382-8
|
Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20383-6
|
Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20384-4
|
Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20385-1
|
Rifampin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20386-9
|
Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20387-7
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20388-5
|
Nitrofurazone [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20389-3
|
Mupirocin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20390-1
|
Silver sulfadiazine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20391-9
|
Mafenide [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20396-8
|
Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20397-6
|
Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20460-2
|
Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20461-0
|
Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20462-8
|
Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
204-8
|
Colistin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
205-5
|
Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20629-2
|
Levofloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
206-3
|
Colistin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
209-7
|
Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
20-8
|
Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
208-9
|
Cyclacillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
210-5
|
Cyclacillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
21070-8
|
Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
212-1
|
Cycloserine [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
21316-5
|
Grepafloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
21367-8
|
Levofloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
213-9
|
Cycloserine [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
214-7
|
Cycloserine [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
21-6
|
Amoxicillin+Clavulanate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
216-2
|
Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
217-0
|
Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23636-4
|
Cefdinir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23637-2
|
Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23638-0
|
Grepafloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23639-8
|
Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23640-6
|
Quinupristin+Dalfopristin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
218-8
|
Demeclocycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
220-4
|
Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
221-2
|
Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
222-0
|
Dicloxacillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
225-3
|
Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
224-6
|
Doxycycline [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
226-1
|
Doxycycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
228-7
|
Enoxacin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
229-5
|
Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
230-3
|
Enoxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23-2
|
Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
232-9
|
Erythromycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
233-7
|
Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
234-5
|
Erythromycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
236-0
|
Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23607-5
|
Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23608-3
|
Cycloserine [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23609-1
|
Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23610-9
|
Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23611-7
|
Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23612-5
|
Azithromycin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23613-3
|
Imipenem [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23614-1
|
Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23615-8
|
Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23616-6
|
Viomycin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23627-3
|
Clofazimine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23628-1
|
Sparfloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23629-9
|
Para aminosalicylate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23641-4
|
Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23642-2
|
Trovafloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23643-0
|
Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23658-8
|
Other Antibiotic [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23659-6
|
Apramycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23709-9
|
Ceftiofur [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23712-3
|
Enrofloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23740-4
|
Florfenicol [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
24-0
|
Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
237-8
|
Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
238-6
|
Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
23925-1
|
Penicillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
244-4
|
Floxacillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
240-2
|
Ethambutol [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
241-0
|
Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
242-8
|
Ethambutol [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
245-1
|
Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
246-9
|
Floxacillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
249-3
|
Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
252-7
|
5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
248-5
|
Fluconazole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25452-4
|
Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25-7
|
Amphotericin B [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
257-6
|
Framycetin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
250-1
|
Fluconazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25174-4
|
Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25175-1
|
Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25176-9
|
Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25177-7
|
Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25178-5
|
Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25179-3
|
Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25180-1
|
Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25181-9
|
Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25182-7
|
Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25183-5
|
Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25184-3
|
Rifampin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25185-0
|
Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25186-8
|
Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25187-6
|
Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25188-4
|
Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25189-2
|
Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25190-0
|
Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25191-8
|
Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25192-6
|
Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25194-2
|
Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25195-9
|
Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25196-7
|
Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25198-3
|
Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25199-1
|
Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25200-7
|
Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25201-5
|
Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25202-3
|
Rifampin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25203-1
|
Rifampin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25204-9
|
Rifampin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25205-6
|
Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25206-4
|
Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25207-2
|
Cycloserine 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25208-0
|
Cycloserine 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25209-8
|
Cycloserine 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25210-6
|
Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25211-4
|
Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25212-2
|
Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25213-0
|
Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25214-8
|
Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25215-5
|
Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25216-3
|
Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25217-1
|
Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25218-9
|
Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25219-7
|
Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25220-5
|
Cefoxitin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25221-3
|
Imipenem 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25222-1
|
Cefmetazole 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25223-9
|
Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25224-7
|
Erythromycin 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25225-4
|
Minocycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25226-2
|
Sulfisoxazole 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25227-0
|
Tobramycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25228-8
|
Vancomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25229-6
|
Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25230-4
|
Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25231-2
|
Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25310-4
|
Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
253-5
|
5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25366-6
|
Cefoxitin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25367-4
|
Ceftriaxone [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25411-0
|
Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
254-3
|
5-Fluorocytosine [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25595-0
|
Econazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25596-8
|
Fosfomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25597-6
|
Josamycine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25607-3
|
Miconazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25608-1
|
Nitroxoline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25637-0
|
Econazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25653-7
|
Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
256-8
|
Foscarnet [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25702-2
|
Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25722-0
|
Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25723-8
|
Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
25800-4
|
Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
258-4
|
Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
259-2
|
Framycetin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
2-6
|
Almecillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
274-1
|
Hetacillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
261-8
|
Fusidate [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
262-6
|
Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
263-4
|
Fusidate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
265-9
|
Ganciclovir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
266-7
|
Gentamicin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
267-5
|
Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
268-3
|
Gentamicin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
278-2
|
Imipenem [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
270-9
|
Gramicidin D [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
271-7
|
Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
272-5
|
Gramicidin D [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
27-3
|
Ampicillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
276-6
|
Hetacillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
275-8
|
Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
279-0
|
Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
280-8
|
Imipenem [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
28-1
|
Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
286-5
|
Isoniazid [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
287-3
|
Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
288-1
|
Isoniazid [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
290-7
|
Kanamycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
291-5
|
Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
292-3
|
Kanamycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
29254-0
|
Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
29255-7
|
Linezolid [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
29258-1
|
Linezolid [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
29315-9
|
Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
294-9
|
Ketoconazole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
296-4
|
Ketoconazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
298-0
|
Lincomycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
295-6
|
Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
29-9
|
Ampicillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
299-8
|
Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
300-4
|
Lincomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
302-0
|
Lomefloxacin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
308-7
|
Loracarbef [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30268-7
|
Zidovudine [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30269-5
|
Lamivudine [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30270-3
|
Didanosine [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30271-1
|
Zalcitabine [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30272-9
|
Stavudine [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30273-7
|
Abacavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30274-5
|
Adefovir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30275-2
|
Nevirapine [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30276-0
|
Delavirdine [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30277-8
|
Efavirenz [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30278-6
|
Indinavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30279-4
|
Ritonavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30280-2
|
Nelfinavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30281-0
|
Saquinavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30282-8
|
Zidovudine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30283-6
|
Lamivudine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30284-4
|
Didanosine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30285-1
|
Zalcitabine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30286-9
|
Stavudine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30287-7
|
Abacavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30288-5
|
Adefovir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30289-3
|
Nevirapine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30290-1
|
Delavirdine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30291-9
|
Efavirenz [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30292-7
|
Indinavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30293-5
|
Ritonavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30294-3
|
Nelfinavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30295-0
|
Saquinavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30296-8
|
Amprenavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30297-6
|
Amprenavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30298-4
|
Lamivudine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30299-2
|
Amprenavir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30300-8
|
Didanosine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30301-6
|
Zalcitabine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30302-4
|
Stavudine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30303-2
|
Abacavir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30304-0
|
Adefovir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30305-7
|
Delavirdine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30306-5
|
Efavirenz [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30307-3
|
Indinavir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30308-1
|
Ritonavir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30309-9
|
Nelfinavir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30310-7
|
Saquinavir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
30311-5
|
Nevirapine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
303-8
|
Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
304-6
|
Lomefloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
306-1
|
Loracarbef [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
307-9
|
Loracarbef [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
310-3
|
Lymecycline [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31036-7
|
Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31037-5
|
Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31038-3
|
Gatifloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31039-1
|
Moxifloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31040-9
|
Gatifloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31041-7
|
Moxifloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31042-5
|
Gatifloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31043-3
|
Moxifloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
311-1
|
Lymecycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31138-1
|
Cefotaxime.meningitis [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31139-9
|
Cefotaxime.meningitis [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31140-7
|
Ceftriaxone.meningitis [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31141-5
|
Ceftriaxone.meningitis [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31142-3
|
Cefepime.meningitis [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31143-1
|
Cefepime.meningitis [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
312-9
|
Lymecycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
314-5
|
Meclocycline [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
31-5
|
Ampicillin+Sulbactam [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
315-2
|
Meclocycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
316-0
|
Meclocycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32-3
|
Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
318-6
|
Methacycline [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
319-4
|
Methacycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
320-2
|
Methacycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
335-0
|
Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
322-8
|
Methicillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
323-6
|
Methicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32372-5
|
Fleroxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32373-3
|
Arbekacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32374-1
|
Cefotiam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32375-8
|
Cefmenoxime [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32376-6
|
Clinafloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32377-4
|
Cefetamet [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32378-2
|
Caspofungin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32379-0
|
Voriconazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32381-6
|
Isepamicin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32383-2
|
Pristinamycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32384-0
|
Thiacetazone [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
324-4
|
Methicillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32597-7
|
Natamycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
32603-3
|
Itraconazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
326-9
|
Metronidazole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
327-7
|
Metronidazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
328-5
|
Metronidazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
330-1
|
Mezlocillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
33-1
|
Ampicillin+Sulbactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
331-9
|
Mezlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
332-7
|
Mezlocillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
33332-8
|
Linezolid [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
33333-6
|
Colistin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
33334-4
|
Quinupristin+Dalfopristin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
334-3
|
Minocycline [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
33627-1
|
Tenofovir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
33628-9
|
Cidofovir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
336-8
|
Minocycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
338-4
|
Miocamycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
339-2
|
Miocamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
3-4
|
Almecillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
340-0
|
Miocamycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
342-6
|
Moxalactam [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
343-4
|
Moxalactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
344-2
|
Moxalactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
34643-7
|
Lopinavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
34644-5
|
Tenofovir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
346-7
|
Nafcillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
347-5
|
Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
348-3
|
Nafcillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
350-9
|
Nalidixate [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
351-7
|
Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
36-4
|
Azithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
352-5
|
Nalidixate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
354-1
|
Neomycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35863-0
|
Voriconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
355-8
|
Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35-6
|
Azithromycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
356-6
|
Neomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35754-1
|
Avilamycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35755-8
|
Avilamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35756-6
|
Avilamycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35757-4
|
Cefdinir [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35758-2
|
Cefdinir [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35759-0
|
Cefditoren [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35760-8
|
Cefditoren [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35761-6
|
Cefditoren [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35762-4
|
Cefditoren [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35763-2
|
Cefepime+Clavulanate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35764-0
|
Cefetamet [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35765-7
|
Cefetamet [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35766-5
|
Cefixime [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35767-3
|
Cefoperazone [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35768-1
|
Cefoperazone+Sulbactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35769-9
|
Cefotaxime+Clavulanate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35770-7
|
Cefotaxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35771-5
|
Cefotaxime+Clavulanate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35772-3
|
Cefotiam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35773-1
|
Cefotiam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35774-9
|
Ceftazidime+Clavulanate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35775-6
|
Ceftazidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35776-4
|
Ceftazidime+Clavulanate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35777-2
|
Ceftibuten [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35778-0
|
Ceftibuten [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35779-8
|
Ceftibuten [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35780-6
|
Ceftiofur [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35781-4
|
Ceftiofur [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35782-2
|
Cefuroxime Oral [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35783-0
|
Cefuroxime Oral [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35784-8
|
Cephalexin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35785-5
|
Clinafloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35786-3
|
Clinafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35787-1
|
Daptomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35788-9
|
Daptomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35789-7
|
Daptomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35790-5
|
Difloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35791-3
|
Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35792-1
|
Difloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35793-9
|
Dirithromycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35794-7
|
Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35795-4
|
Dirithromycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35796-2
|
Enrofloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35797-0
|
Enrofloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35798-8
|
Enrofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35799-6
|
Ertapenem [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35800-2
|
Ertapenem [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35801-0
|
Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35802-8
|
Ertapenem [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35803-6
|
Bambermycins [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35804-4
|
Bambermycins [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35805-1
|
Bambermycins [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35806-9
|
Fleroxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35807-7
|
Florfenicol [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35808-5
|
Florfenicol [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35809-3
|
Fosfomycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35810-1
|
Fosfomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35811-9
|
Garenoxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35812-7
|
Garenoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35813-5
|
Garenoxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35814-3
|
Gemifloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35815-0
|
Gemifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35816-8
|
Gemifloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35817-6
|
Gentamicin.high potency [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35818-4
|
Grepafloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35819-2
|
Imipenem+EDTA [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
358-2
|
Netilmicin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35820-0
|
Isepamicin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35821-8
|
Isepamicin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35822-6
|
Mupirocin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35823-4
|
Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35824-2
|
Nystatin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35825-9
|
Orbifloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35826-7
|
Orbifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35827-5
|
Orbifloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35828-3
|
Pefloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35829-1
|
Pirlimycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35830-9
|
Pirlimycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35831-7
|
Pirlimycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35832-5
|
Polymyxin B [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35833-3
|
Pristinamycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35834-1
|
Pristinamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35835-8
|
Quinupristin+Dalfopristin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35836-6
|
Salinomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35837-4
|
Salinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35838-2
|
Salinomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35839-0
|
Sparfloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35840-8
|
Spectinomycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35841-6
|
Streptomycin.high potency [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35842-4
|
Sulfonamide [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35843-2
|
Telithromycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35844-0
|
Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35845-7
|
Telithromycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35846-5
|
Tiamulin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35847-3
|
Tiamulin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35848-1
|
Tiamulin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35849-9
|
Tilmicosin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35850-7
|
Tilmicosin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35851-5
|
Tilmicosin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35852-3
|
Trospectinomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35853-1
|
Trospectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35854-9
|
Trospectinomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35855-6
|
Trovafloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35856-4
|
Tylosin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35857-2
|
Tylosin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35858-0
|
Tylosin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35859-8
|
Virginiamycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35860-6
|
Virginiamycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35861-4
|
Virginiamycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35862-2
|
Voriconazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35872-1
|
Penicillin+Novobiocin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35873-9
|
Penicillin+Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
35874-7
|
Penicillin+Novobiocin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
359-0
|
Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
360-8
|
Netilmicin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
362-4
|
Nitrofurantoin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
363-2
|
Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
364-0
|
Nitrofurantoin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
366-5
|
Norfloxacin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
367-3
|
Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
368-1
|
Norfloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
370-7
|
Novobiocin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
371-5
|
Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
37-2
|
Azithromycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
372-3
|
Novobiocin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
374-9
|
Ofloxacin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
375-6
|
Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
376-4
|
Ofloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
392-1
|
Penicillin G [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
378-0
|
Oleandomycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
379-8
|
Oleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
380-6
|
Oleandomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
382-2
|
Oxacillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
383-0
|
Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
384-8
|
Oxacillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
386-3
|
Oxytetracycline [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
387-1
|
Oxytetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
388-9
|
Oxytetracycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
390-5
|
Pefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
391-3
|
Penicillin G [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
393-9
|
Penicillin G [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
395-4
|
Penicillin V [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
396-2
|
Penicillin V [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
397-0
|
Penicillin V [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
39-8
|
Azlocillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
399-6
|
Phenethicillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
400-2
|
Phenethicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
401-0
|
Phenethicillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
403-6
|
Pipemidate [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
404-4
|
Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
405-1
|
Pipemidate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
40-6
|
Azlocillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
407-7
|
Piperacillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
408-5
|
Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
409-3
|
Piperacillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41408-6
|
Ofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41409-4
|
Ofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41410-2
|
Ofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41031-6
|
Lopinavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41993-7
|
Atazanavir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
411-9
|
Piperacillin+Tazobactam [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41199-1
|
Voriconazole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41200-7
|
Voriconazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
412-7
|
Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
413-5
|
Piperacillin+Tazobactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41396-3
|
Tenofovir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41-4
|
Azlocillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41402-9
|
Emtricitabine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41403-7
|
Atazanavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41494-6
|
Gatifloxacin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
415-0
|
Pivampicillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41500-0
|
Linezolid [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41502-6
|
Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41504-2
|
Norfloxacin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41658-6
|
ABT492 [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41659-4
|
ABT492 [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41660-2
|
ABT492 [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41661-0
|
Azlocillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41662-8
|
Aztreonam+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41663-6
|
Aztreonam+Clavulanate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41664-4
|
Aztreonam+Clavulanate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41665-1
|
Biapenem [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41666-9
|
Biapenem [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41667-7
|
Biapenem [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41668-5
|
Carbenicillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41669-3
|
Cefamandole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41670-1
|
Cefazolin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41671-9
|
Cefotaxime+Clavulanate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41672-7
|
Cefotetan+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41673-5
|
Cefotetan+Clavulanate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41674-3
|
Cefotetan+Clavulanate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41675-0
|
Cefoxitin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41676-8
|
Cefoxitin+Clavulanate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41677-6
|
Cefoxitin+Clavulanate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41678-4
|
Cefpodoxime+Clavulanate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41679-2
|
Cefpodoxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
416-8
|
Pivampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41680-0
|
Cefpodoxime+Clavulanate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41681-8
|
Ceftriaxone+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41682-6
|
Ceftriaxone+Clavulanate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41683-4
|
Ceftriaxone+Clavulanate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41684-2
|
Cephaloridine [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41685-9
|
Clavulanate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41686-7
|
Clavulanate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41687-5
|
Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41688-3
|
Dalbavancin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41689-1
|
Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41690-9
|
Dalbavancin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41691-7
|
Daptomycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41692-5
|
Enoxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41693-3
|
Ethionamide [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41694-1
|
Everninomicin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41695-8
|
Everninomicin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41696-6
|
Everninomicin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41697-4
|
Gemifloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41698-2
|
Josamycine [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41699-0
|
Josamycine [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41700-6
|
Lincomycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41701-4
|
Lomefloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41702-2
|
Mezlocillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41703-0
|
Moxalactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41704-8
|
Nafcillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41705-5
|
Neomycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41706-3
|
Novobiocin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41707-1
|
Oritavancin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41708-9
|
Oritavancin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41709-7
|
Oritavancin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41710-5
|
Ramoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41711-3
|
Ramoplanin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41712-1
|
Ramoplanin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41713-9
|
Rosamicin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41714-7
|
Rosamicin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41715-4
|
Rosamicin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41716-2
|
Sulbactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41717-0
|
Sulbactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41718-8
|
Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41719-6
|
Tazobactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41720-4
|
Tazobactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41721-2
|
Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41722-0
|
Telithromycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41723-8
|
Thiamphenicol [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41724-6
|
Thiamphenicol [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41725-3
|
Thiamphenicol [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41726-1
|
ABT492 [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41727-9
|
Aztreonam+Clavulanate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41728-7
|
Biapenem [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41729-5
|
Cefotetan+Clavulanate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41730-3
|
Cefoxitin+Clavulanate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41731-1
|
Cefpodoxime+Clavulanate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41732-9
|
Ceftriaxone+Clavulanate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41733-7
|
Clavulanate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41734-5
|
Dalbavancin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41735-2
|
Everninomicin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41736-0
|
Oritavancin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41737-8
|
Ramoplanin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41738-6
|
Rosamicin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41739-4
|
Sulbactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
41740-2
|
Tazobactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
417-6
|
Pivampicillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
419-2
|
Polymyxin B [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
4-2
|
Almecillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
420-0
|
Polymyxin B [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42000-0
|
Lopinavir+Ritonavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
421-8
|
Polymyxin B [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42317-8
|
Foscarnet [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
423-4
|
Pyrazinamide [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42350-9
|
Cefepime+Clavulanate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42351-7
|
Cefepime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42352-5
|
Ceftazidime+Clavulanate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42353-3
|
Cefepime+Clavulanate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42354-1
|
Tigecycline [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42355-8
|
Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42356-6
|
Tigecycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42357-4
|
Tigecycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
424-2
|
Pyrazinamide [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42500-9
|
Fosamprenavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42535-5
|
Tipranavir [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
425-9
|
Pyrazinamide [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42642-9
|
Amikacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42651-0
|
Isoniazid 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42655-1
|
Rifabutin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
42720-3
|
Clindamycin.induced [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
427-5
|
Rifampin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
428-3
|
Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
429-1
|
Rifampin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43-0
|
Aztreonam [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
431-7
|
Ristocetin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
432-5
|
Ristocetin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43269-0
|
Ceftobiprole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43270-8
|
Ceftobiprole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43271-6
|
Ceftobiprole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43272-4
|
Ceftobiprole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
433-3
|
Ristocetin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
435-8
|
Rolitetracycline [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
436-6
|
Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43736-8
|
Fosamprenavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43737-6
|
Tipranavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
437-4
|
Rolitetracycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
439-0
|
Rosoxacin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43986-9
|
Clofazimine 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43987-7
|
Clarithromycin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43988-5
|
Clofazimine 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43989-3
|
Clofazimine 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43990-1
|
Clarithromycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
43991-9
|
Clarithromycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
440-8
|
Rosoxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
441-6
|
Rosoxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
443-2
|
Roxithromycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
444-0
|
Roxithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
445-7
|
Roxithromycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
447-3
|
Sisomicin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
44-8
|
Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
448-1
|
Sisomicin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
449-9
|
Sisomicin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
451-5
|
Spectinomycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
45182-3
|
HIV phenotype [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
45187-2
|
Other Antibiotic [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
45215-1
|
Isoniazid 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
452-3
|
Spectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
453-1
|
Spectinomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
45-5
|
Aztreonam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
455-6
|
Spiramycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
456-4
|
Spiramycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
457-2
|
Spiramycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
459-8
|
Streptomycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
460-6
|
Streptomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
461-4
|
Streptomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
465-5
|
Sulfadiazine [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
463-0
|
Sulfadiazine [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
464-8
|
Sulfadiazine [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
467-1
|
Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
46719-1
|
Streptomycin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
468-9
|
Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
469-7
|
Sulfamethoxazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
47-1
|
Bacampicillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
471-3
|
Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
472-1
|
Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
473-9
|
Sulfisoxazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
475-4
|
Sulfonamide [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
476-2
|
Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
477-0
|
Sulfonamide [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
48169-7
|
Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
48170-5
|
Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
48173-9
|
Levofloxacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
48558-1
|
HIV genotype [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
479-6
|
Talampicillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
480-4
|
Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
481-2
|
Talampicillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
48177-0
|
Streptomycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
483-8
|
Teicoplanin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
484-6
|
Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
485-3
|
Teicoplanin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
48685-2
|
Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
487-9
|
Temafloxacin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
488-7
|
Temafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
48-9
|
Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
489-5
|
Temafloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49080-5
|
Kanamycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
491-1
|
Temocillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
492-9
|
Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
493-7
|
Temocillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
495-2
|
Tetracycline [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49573-9
|
HIV genotype [Susceptibility] in Isolate by Genotype method Narrative
|
Logical Observation Identifier Names and Codes |
| 0‑L |
496-0
|
Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49618-2
|
Atazanavir+Ritonavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49619-0
|
Indinavir+Ritonavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49620-8
|
Lamivudine or Emtricitabine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49621-6
|
Saquinavir+Ritonavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49622-4
|
Tipranavir+Ritonavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49623-2
|
Amprenavir or Fosamprenavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49630-7
|
Darunavir+Ritonavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49666-1
|
Darunavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49667-9
|
Tipranavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49668-7
|
Atazanavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49669-5
|
Emtricitabine [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
49-7
|
Bacampicillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
497-8
|
Tetracycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
511-6
|
Trimethoprim [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
499-4
|
Ticarcillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
500-9
|
Ticarcillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
504-1
|
Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
50630-3
|
Gentamicin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
50631-1
|
Cefepime [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
50632-9
|
Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
50633-7
|
Ceftriaxone.meningitis [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
501-7
|
Ticarcillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
503-3
|
Ticarcillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
505-8
|
Ticarcillin+Clavulanate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
50703-8
|
Influenza virus A.neuraminidase inhibitor resistance [Susceptibility] Qualitative
by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
50712-9
|
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] Qualitative
|
Logical Observation Identifier Names and Codes |
| 0‑L |
50713-7
|
Influenza virus.neuraminidase inhibitor resistance [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
507-4
|
Tobramycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
508-2
|
Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
509-0
|
Tobramycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
51698-9
|
Dapsone [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
512-4
|
Trimethoprim [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
51-3
|
Butirosin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
513-2
|
Trimethoprim [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
51409-1
|
Fosamprenavir+Ritonavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
51719-3
|
Paromomycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
51503-1
|
Penicillin G procaine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
51504-9
|
Penicillin G benzathine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
515-7
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
516-5
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration
(MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
51694-8
|
Carumonam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
51724-3
|
Cefuroxime [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
517-3
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
52749-9
|
Etravirine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
51774-8
|
Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
519-9
|
Troleandomycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
520-7
|
Troleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
52-1
|
Butirosin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
52128-6
|
Cefotaxime.meningitis [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
521-5
|
Troleandomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
523-1
|
Vancomycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
524-9
|
Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
525-6
|
Vancomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
527-2
|
Viomycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
528-0
|
Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
529-8
|
Viomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
531-4
|
Zidovudine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
53716-7
|
Levofloxacin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
53812-4
|
Micafungin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
53818-1
|
Arbekacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
53820-7
|
Cefozopran [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
53822-3
|
Flomoxef [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
53823-1
|
Panipenem [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
53824-9
|
Paromomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
53-9
|
Butirosin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54166-4
|
Cefoperazone+Sulbactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54167-2
|
Cefoperazone+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54168-0
|
Cefoperazone+Sulbactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54169-8
|
Thiamphenicol [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54170-6
|
Imipenem+EDTA [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54171-4
|
Imipenem+EDTA [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54172-2
|
Imipenem+EDTA [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54173-0
|
Arbekacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54174-8
|
Cefmenoxime [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54175-5
|
Caspofungin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54176-3
|
Caspofungin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54177-1
|
Clotrimazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54178-9
|
Econazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54179-7
|
Itraconazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54180-5
|
Miconazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54181-3
|
Nitroxoline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54182-1
|
Para aminosalicylate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54183-9
|
Rifabutin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54184-7
|
Thiacetazone [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54185-4
|
Caspofungin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54186-2
|
Posaconazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54187-0
|
Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54188-8
|
Posaconazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54189-6
|
Posaconazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54190-4
|
Temocillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54191-2
|
Cefotaxime+Sulbactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54192-0
|
Cefotaxime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54193-8
|
Cefotaxime+Sulbactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54194-6
|
Mezlocillin+Sulbactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54195-3
|
Mezlocillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54196-1
|
Mezlocillin+Sulbactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54197-9
|
Piperacillin+Sulbactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54198-7
|
Piperacillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54199-5
|
Piperacillin+Sulbactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54200-1
|
Griseofulvin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54201-9
|
Griseofulvin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54202-7
|
Griseofulvin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54203-5
|
Cefmenoxime [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54204-3
|
Thiacetazone [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54908-9
|
Cefminox [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
54928-7
|
Tinidazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55091-3
|
Darunavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55189-5
|
Cefotaxime.meningitis [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55190-3
|
Ceftriaxone.meningitis [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55136-6
|
Penicillin Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55137-4
|
Penicillin Parenteral.meningitis [Susceptibility] by Minimum inhibitory concentration
(MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55154-9
|
Ethambutol+Rifampin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55156-4
|
Minocycline [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55158-0
|
Tigecycline [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55194-5
|
Ciprofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55196-0
|
Terconazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55711-6
|
Pyrazinamide 200 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55712-4
|
Rifampin 40 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55713-2
|
Rosoxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55714-0
|
Sisomicin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55715-7
|
Spiramycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55716-5
|
Ticarcillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55717-3
|
Ticarcillin+Sulbactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55289-3
|
Sulopenem [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55290-1
|
Sulopenem [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55291-9
|
Sulopenem [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55292-7
|
Linopristin+Flopristin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55293-5
|
Linopristin+Flopristin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55294-3
|
Linopristin+Flopristin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55343-8
|
Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55-4
|
Capreomycin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55655-5
|
Chlortetracycline [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55656-3
|
Cinoxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55657-1
|
Clindamycin.high potency [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55658-9
|
Clindamycin.high potency [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55659-7
|
Clindamycin.high potency [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55660-5
|
Clindamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55661-3
|
Clofazimine [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55662-1
|
Clofazimine [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55663-9
|
Clotrimazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55664-7
|
Cloxacillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55614-2
|
Amoxicillin+Sulbactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55615-9
|
Amoxicillin+Sulbactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55616-7
|
Amoxicillin+Sulbactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55617-5
|
Other Antibiotic [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55618-3
|
Atovaquone [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55619-1
|
Avilamycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55620-9
|
Bacampicillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55621-7
|
Bambermycins [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55622-5
|
Butirosin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55623-3
|
Capreomycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55624-1
|
Cefacetrile [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55625-8
|
Cefacetrile [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55626-6
|
Cefacetrile [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55627-4
|
Cefacetrile [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55628-2
|
Cefadroxil [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55629-0
|
Cephaloglycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55630-8
|
Cephalothin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55631-6
|
Cephalothin+Sulbactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55632-4
|
Cephalothin+Sulbactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55633-2
|
Cephalothin+Sulbactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55634-0
|
Cefamandole+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55635-7
|
Cefamandole+Sulbactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55636-5
|
Cefamandole+Sulbactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55637-3
|
Cefamandole+Sulbactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55638-1
|
Cephapirin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55639-9
|
Cefatrizine [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55640-7
|
Cefetamet [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55641-5
|
Cefmenoxime [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55642-3
|
Cefonicid [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55737-1
|
Cefotiam hexetil [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55738-9
|
Cefotiam hexetil [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55739-7
|
Cefotiam hexetil [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55740-5
|
Cefotiam hexetil [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55643-1
|
Ceforanide [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55644-9
|
Cefotaxime+Sulbactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55645-6
|
Cefotiam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55646-4
|
Cephradine [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55647-2
|
Cefsulodin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55648-0
|
Ceftazidime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55649-8
|
Ceftazidime+Sulbactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55650-6
|
Ceftazidime+Sulbactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55651-4
|
Ceftazidime+Sulbactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55652-2
|
Ceftiofur [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55653-0
|
Cefuroxime Oral [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55654-8
|
Cefuroxime [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55665-4
|
Colistimethate by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55666-2
|
Cyclacillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55667-0
|
Cycloserine [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55668-8
|
Dicloxacillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55669-6
|
Dibekacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55670-4
|
Dibekacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55671-2
|
Dibekacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55672-0
|
Dibekacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55673-8
|
Econazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55674-6
|
Ethambutol 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55675-3
|
Flumequine [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55676-1
|
Flumequine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55677-9
|
Flumequine [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55678-7
|
Flumequine [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55679-5
|
Framycetin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55680-3
|
Isepamicin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55681-1
|
Isoconazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55682-9
|
Isoconazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55683-7
|
Isoconazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55684-5
|
Isoconazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55685-2
|
Isoniazid 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55686-0
|
Miconazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55687-8
|
Miocamycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55688-6
|
Nitroxoline [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55689-4
|
Nystatin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55690-2
|
Oleandomycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55691-0
|
Ornidazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55692-8
|
Ornidazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55693-6
|
Ornidazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55694-4
|
Ornidazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55695-1
|
Oxolinate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55696-9
|
Oxolinate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55697-7
|
Oxolinate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55698-5
|
Oxolinate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55699-3
|
Oxytetracycline [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55701-7
|
Paromomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55702-5
|
Paromomycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55703-3
|
Pipemidate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55704-1
|
Piperacillin+Sulbactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55705-8
|
Piromidate [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55706-6
|
Piromidate [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55707-4
|
Piromidate [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55708-2
|
Piromidate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55709-0
|
Pristinamycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55710-8
|
Pyrazinamide [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55718-1
|
Ticarcillin+Sulbactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55719-9
|
Ticarcillin+Sulbactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55720-7
|
Tinidazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55721-5
|
Tinidazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55722-3
|
Tinidazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
55723-1
|
Virginiamycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
57-0
|
Capreomycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
56025-0
|
Ethambutol 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
56026-8
|
Pyrazinamide 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
56031-8
|
Doripenem [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
56-2
|
Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
56791-7
|
Entecavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
56792-5
|
Telbivudine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
57095-2
|
Anidulafungin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
57895-5
|
Influenza virus A H1.neuraminidase inhibitor resistance [Susceptibility] in Unspecified
specimen by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
57896-3
|
Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance [Susceptibility] in
Unspecified specimen by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
57897-1
|
Influenza virus A+B.neuraminidase inhibitor resistance [Susceptibility] in Unspecified
specimen by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
57907-8
|
Atazanavir+Ritonavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
57955-7
|
Darunavir+Ritonavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
57965-6
|
Fosamprenavir+Ritonavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
57984-7
|
Indinavir+Ritonavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
57997-9
|
Lopinavir+Ritonavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
58705-5
|
Ceftazidime [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
58024-1
|
Saquinavir+Ritonavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
58029-0
|
Tipranavir+Ritonavir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
58080-3
|
Penicillin Parenteral.meningitis [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
58085-2
|
Penicillin Parenteral [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
58412-8
|
Cefepime.meningitis [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
58711-3
|
Doripenem [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
58712-1
|
Quinupristin+Dalfopristin [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
59-6
|
Carbenicillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
59833-4
|
Other Antibiotic [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
60-4
|
Carbenicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
60440-5
|
Oseltamivir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
60441-3
|
Oseltamivir+Zanamivir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
60535-2
|
Doripenem [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
60542-8
|
Mupirocin 5 ug [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
60543-6
|
Mupirocin 200 ug [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
60564-2
|
Amikacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
60565-9
|
Amikacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
61188-9
|
Clindamycin.induced [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
61198-8
|
Raltegravir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
61-2
|
Carbenicillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
61355-4
|
Capreomycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
62237-3
|
Carbapenemase [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
63565-6
|
Prothionamide [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
63-8
|
Cefadroxil [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
64-6
|
Cefadroxil [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
65-3
|
Cefadroxil [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
65340-2
|
Micafungin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6643-1
|
Cefepime [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6644-9
|
Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6651-4
|
Meropenem [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6652-2
|
Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6653-0
|
Meropenem [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6-7
|
Amantadine [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
68-7
|
Cefamandole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
67-9
|
Cefamandole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6827-0
|
Bacitracin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
68463-9
|
Rilpivirine [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6932-8
|
Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6933-6
|
Streptomycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6998-9
|
Ceftriaxone [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6999-7
|
Cefuroxime Parenteral [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7000-3
|
Cephalothin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6976-5
|
Amoxicillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7020-1
|
Isoniazid [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7047-4
|
Sparfloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
69-5
|
Cefamandole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
69574-2
|
Furazolidone [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6975-7
|
Amikacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6977-3
|
Amoxicillin+Clavulanate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6978-1
|
Amphotericin B [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6979-9
|
Ampicillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6980-7
|
Ampicillin+Sulbactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6981-5
|
Azithromycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6982-3
|
Aztreonam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6983-1
|
Bacitracin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6984-9
|
Beta lactamase.extended spectrum [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6985-6
|
Beta lactamase.usual [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6986-4
|
Cefaclor [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6987-2
|
Cefepime [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6988-0
|
Cefodizime [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6989-8
|
Cefotaxime [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6990-6
|
Cefotetan [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6991-4
|
Cefoxitin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6992-2
|
Cefpirome [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6993-0
|
Cefpodoxime [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6994-8
|
Cefprozil [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6995-5
|
Ceftazidime [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6996-3
|
Ceftibuten [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
6997-1
|
Ceftizoxime [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7001-1
|
Chloramphenicol [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7002-9
|
Ciprofloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7003-7
|
Clarithromycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7004-5
|
Clinafloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7005-2
|
Clindamycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7006-0
|
Demeclocycline [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7007-8
|
Dirithromycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7008-6
|
Doxycycline [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7009-4
|
Erythromycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7010-2
|
Ethambutol [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7011-0
|
Ethionamide [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7012-8
|
Fleroxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7034-2
|
Nalidixate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7039-1
|
Oxacillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7058-1
|
Trovafloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7013-6
|
Fluconazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7014-4
|
5-Fluorocytosine [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7015-1
|
Fusidate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7016-9
|
Gentamicin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7017-7
|
Gentamicin.high potency [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7018-5
|
Gentamicin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7019-3
|
Imipenem [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7021-9
|
Itraconazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7022-7
|
Kanamycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7023-5
|
Kanamycin.high potency [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7024-3
|
Kanamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7025-0
|
Ketoconazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7026-8
|
Levofloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7027-6
|
Loracarbef [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7028-4
|
Amdinocillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7029-2
|
Meropenem [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7030-0
|
Methicillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7031-8
|
Metronidazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7032-6
|
Minocycline [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7033-4
|
Mupirocin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7035-9
|
Netilmicin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7036-7
|
Nitrofurantoin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7037-5
|
Norfloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7038-3
|
Ofloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7040-9
|
Pefloxacin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7041-7
|
Penicillin G [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7042-5
|
Penicillin V [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7043-3
|
Piperacillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7044-1
|
Piperacillin+Tazobactam [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7045-8
|
Rifampin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7046-6
|
Roxithromycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7048-2
|
Streptomycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7049-0
|
Streptomycin.high potency [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7050-8
|
Sulfadiazine [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7051-6
|
Teicoplanin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7052-4
|
Tetracycline [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7053-2
|
Ticarcillin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7054-0
|
Ticarcillin+Clavulanate [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7055-7
|
Tobramycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7056-5
|
Trimethoprim [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7057-3
|
Trimethoprim+Sulfamethoxazole [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7059-9
|
Vancomycin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
71-1
|
Cefatrizine [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72557-2
|
Rilpivirine [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72558-0
|
Etravirine [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72168-8
|
Ofloxacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72525-9
|
Raltegravir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72526-7
|
Elvitegravir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73633-0
|
Sarafloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73634-8
|
Rifaximin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73635-5
|
Razupenem [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73636-3
|
Premafloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73637-1
|
Plazomicin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73638-9
|
Ormetroprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73639-7
|
Omadacycline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73640-5
|
Nitazoxanide [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72834-5
|
Foscarnet [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72839-4
|
Famciclovir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72853-5
|
Maribavir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72854-3
|
Ganciclovir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72855-0
|
Cidofovir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72856-8
|
Cidofovir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72857-6
|
Dolutegravir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72858-4
|
Enfuvirtide [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72859-2
|
Boceprevir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72860-0
|
Telaprevir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72861-8
|
Ganciclovir [Susceptibility] by Phenotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72893-1
|
Doripenem [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72894-9
|
Telavancin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
72-9
|
Cefatrizine [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73585-2
|
Tizoxanide [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73586-0
|
Tedizolid [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73587-8
|
Solithromycin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73588-6
|
Sarafloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73589-4
|
Rifaximin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73590-2
|
Razupenem [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73591-0
|
Premafloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73592-8
|
Plazomicin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73619-9
|
Iclaprim [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73620-7
|
Finafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73621-5
|
Fidaxomicin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73622-3
|
Faropenem [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73623-1
|
Danofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73624-9
|
Ceftolozane+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73574-6
|
Acyclovir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73593-6
|
Ormetroprim+Sulfamethoxazole [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73594-4
|
Omadacycline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73595-1
|
Nitazoxanide [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73596-9
|
Marbofloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73597-7
|
Iclaprim [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73598-5
|
Finafloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73599-3
|
Fidaxomicin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73600-9
|
Faropenem [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73601-7
|
Danofloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73602-5
|
Ceftolozane+Tazobactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73603-3
|
Ceftazidime+Avibactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73604-1
|
Ceftaroline+Avibactam [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73605-8
|
Ceftaroline [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73606-6
|
Besifloxacin [Susceptibility]
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73607-4
|
Tizoxanide [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73608-2
|
Tedizolid [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73609-0
|
Solithromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73610-8
|
Sarafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73611-6
|
Rifaximin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73612-4
|
Razupenem [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73613-2
|
Premafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73614-0
|
Plazomicin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73615-7
|
Ormetroprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration
(MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73616-5
|
Omadacycline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73617-3
|
Nitazoxanide [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73618-1
|
Marbofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73625-6
|
Ceftazidime+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73626-4
|
Ceftaroline+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73627-2
|
Ceftaroline [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73628-0
|
Besifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73629-8
|
Tizoxanide [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73630-6
|
Telavancin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73631-4
|
Tedizolid [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73632-2
|
Solithromycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73641-3
|
Marbofloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73642-1
|
Iclaprim [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73643-9
|
Finafloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73644-7
|
Fidaxomicin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73645-4
|
Faropenem [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73646-2
|
Danofloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73647-0
|
Ceftolozane+Tazobactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73648-8
|
Ceftazidime+Avibactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73649-6
|
Ceftaroline+Avibactam [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73650-4
|
Ceftaroline [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73651-2
|
Besifloxacin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73652-0
|
Apramycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73653-8
|
Apramycin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73665-2
|
Optochin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
73-7
|
Cefatrizine [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
74170-2
|
Ceftaroline [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
74699-0
|
Cefuroxime [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76040-5
|
Levofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76041-3
|
Levofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
7-5
|
Amdinocillin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
75029-9
|
Zanamivir [Susceptibility] by Genotype method
|
Logical Observation Identifier Names and Codes |
| 0‑L |
75-2
|
Cefazolin [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76-0
|
Cefazolin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76042-1
|
Levofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76043-9
|
Moxifloxacin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76044-7
|
Moxifloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76045-4
|
Moxifloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76143-7
|
Cefcapene [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76144-5
|
Cefteram [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76145-2
|
Prulifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76146-0
|
Tosufloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76147-8
|
Cefovecin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76148-6
|
Pradofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76149-4
|
Tulathromycin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76150-2
|
Cefquinome [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
76627-9
|
Rifapentine [Susceptibility] by Method for Slow-growing mycobacteria
|
Logical Observation Identifier Names and Codes |
| 0‑L |
77162-6
|
Anidulafungin [Susceptibility] by Gradient strip
|
Logical Observation Identifier Names and Codes |
| 0‑L |
77-8
|
Cefazolin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
77960-3
|
Penicillin Parenteral [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
78004-9
|
Staphylococcus aureus.vancomycin resistance [Susceptibility] Qualitative
|
Logical Observation Identifier Names and Codes |
| 0‑L |
79-4
|
Cefixime [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
80-2
|
Cefixime [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
81-0
|
Cefixime [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
8272-7
|
Cefepime [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
8274-3
|
Cefpirome [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
8275-0
|
Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
8276-8
|
Cefpirome [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
8-3
|
Amdinocillin [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
83-6
|
Cefaclor [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
84-4
|
Cefaclor [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
85-1
|
Cefaclor [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
87-7
|
Cefmetazole [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
88-5
|
Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
89-3
|
Cefmetazole [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
96-8
|
Cefonicid [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
91-9
|
Cefodizime [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
9-1
|
Amdinocillin [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
92-7
|
Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
93-5
|
Cefodizime [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
95-0
|
Cefonicid [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
97-6
|
Cefonicid [Susceptibility] by Disk diffusion (KB)
|
Logical Observation Identifier Names and Codes |
| 0‑L |
99-2
|
Cefoperazone [Susceptibility] by Minimum lethal concentration (MLC)
|
Logical Observation Identifier Names and Codes |
|
| |
Value Set ELGA_Antibiotika 2016‑11‑24
Definitiv
